Wakamoto Pharmaceutical Co Ltd: Notice on the suspension of the development of the therapeutic agent "WP-1303" for glaucoma hypertension

JPX · Sep 9, 2019 18:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.